| First Author | Pavlides S | Year | 2014 |
| Journal | Cell Tissue Res | Volume | 358 |
| Issue | 3 | Pages | 821-31 |
| PubMed ID | 25322709 | Mgi Jnum | J:328437 |
| Mgi Id | MGI:6839051 | Doi | 10.1007/s00441-014-2008-4 |
| Citation | Pavlides S, et al. (2014) Caveolin-1 regulates the anti-atherogenic properties of macrophages. Cell Tissue Res 358(3):821-31 |
| abstractText | Atherosclerosis is a complex disease initiated by the vascular accumulation of lipoproteins in the sub-endothelial space, followed by the infiltration of monocytes into the arterial intima. Caveolin-1 (Cav-1) plays an essential role in the regulation of cellular cholesterol metabolism and of various signaling pathways. In order to study specifically the role of macrophage Cav-1 in atherosclerosis, we used Cav-1 (-/-) Apoe (-/-) mice and transplanted them with bone marrow (BM) cells obtained from Cav-1 (+/+) Apoe (-/-) or Cav-1 (-/-) Apoe (-/-) mice and vice versa. We found that Cav-1 (+/+) mice harboring Cav-1 (-/-) BM-derived macrophages developed significantly larger lesions than Cav-1 (+/+) mice harboring Cav-1 (+/+) BM-derived macrophages. Cav-1 (-/-) macrophages were more susceptible to apoptosis and more prone to induce inflammation. The present study provides clear evidence that the absence of Cav-1 in macrophage is pro-atherogenic, whereas its absence in endothelial cells protects against atherosclerotic lesion formation. These findings demonstrate the cell-specific role of Cav-1 during the development of this disease. |
